{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:22:51Z","timestamp":1786551771462,"version":"build-2736575974"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03889-6","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T08:01:48Z","timestamp":1751443308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Regulatory mechanisms and clinical implications of PIWI-interacting RNAs (piRNAs) in major digestive tract cancers"],"prefix":"10.1186","volume":"25","author":[{"given":"Penghui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"3889_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S2468-1253(23)00366-7","volume":"9","author":"S Wang","year":"2024","unstructured":"Wang S, Zheng R, Li J, Zeng H, Li L, Chen R, et al. Global, regional, and National lifetime risks of developing and dying from Gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN. Lancet Gastroenterol Hepatol. 2024;9:229\u201337.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3889_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcancer.2017.12.004","volume":"51","author":"HM Vedeld","year":"2018","unstructured":"Vedeld HM, Goel A, Lind GE. Epigenetic biomarkers in Gastrointestinal cancers: the current state and clinical perspectives. Semin Cancer Biol. 2018;51:36\u201349.","journal-title":"Semin Cancer Biol"},{"key":"3889_CR3","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1158\/1078-0432.CCR-16-1676","volume":"23","author":"K Shigeyasu","year":"2017","unstructured":"Shigeyasu K, Toden S, Zumwalt TJ, Okugawa Y, Goel A. Emerging role of MicroRNAs as liquid biopsy biomarkers in Gastrointestinal cancers. Clin Cancer Res. 2017;23:2391\u20139.","journal-title":"Clin Cancer Res"},{"key":"3889_CR4","doi-asserted-by":"crossref","unstructured":"Huang J, Lucero-Prisno DE 3rd, Zhang L, Xu W, Wong SH, Ng SC, et al. Updated epidemiology of Gastrointestinal cancers in East Asia. Nat Rev Gastroenterol Hepatol. 2023;20:271\u201387.","DOI":"10.1038\/s41575-022-00726-3"},{"issue":"Suppl 3","key":"3889_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.0953-0673.2003.01722.x","volume":"18","author":"MR Keighley","year":"2003","unstructured":"Keighley MR. Gastrointestinal cancers in Europe. Aliment Pharmacol Ther. 2003;18(Suppl 3):7\u201330.","journal-title":"Aliment Pharmacol Ther"},{"key":"3889_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S2468-1253(20)30045-5","volume":"5","author":"S Pinion","year":"2020","unstructured":"Pinion S. ASCO 2020 Gastrointestinal cancers symposium. Lancet Gastroenterol Hepatol. 2020;5:338.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3889_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.14309\/ajg.0000000000002526","volume":"119","author":"CC Murphy","year":"2024","unstructured":"Murphy CC, Tavakkoli A, Wani S, Singal AG. Pandemic-Related changes in incidence and mortality rates of Gastrointestinal cancers during 2020. Am J Gastroenterol. 2024;119:382\u20137.","journal-title":"Am J Gastroenterol"},{"key":"3889_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrgastro.2017.33","volume":"14","author":"MF Bijlsma","year":"2017","unstructured":"Bijlsma MF, Sadanandam A, Tan P, Vermeulen L. Molecular subtypes in cancers of the Gastrointestinal tract. Nat Rev Gastroenterol Hepatol. 2017;14:333\u201342.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3889_CR9","first-page":"705","volume":"164","author":"EM Stoffel","year":"2023","unstructured":"Stoffel EM, Eng C. Assessing risk for Gastrointestinal cancers. Forewarned Is Forearmed\u2026 Gastroenterol. 2023;164:705\u20136.","journal-title":"Forewarned Is Forearmed\u2026 Gastroenterol"},{"key":"3889_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1158\/2159-8290.CD-22-1038","volume":"13","author":"I Ben-Aharon","year":"2023","unstructured":"Ben-Aharon I, van Laarhoven HWM, Fontana E, Obermannova R, Nilsson M, Lordick F. Early-Onset Cancer in the Gastrointestinal tract is on the Rise-Evidence and implications. Cancer Discov. 2023;13:538\u201351.","journal-title":"Cancer Discov"},{"key":"3889_CR11","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1111\/j.1572-0241.2008.01994.x","volume":"103","author":"R Badreddine","year":"2008","unstructured":"Badreddine R, Wang KK. Biomarkers in Gastrointestinal cancers. Am J Gastroenterol. 2008;103:2106\u201310.","journal-title":"Am J Gastroenterol"},{"key":"3889_CR12","doi-asserted-by":"publisher","first-page":"16816","DOI":"10.3390\/ijms150916816","volume":"15","author":"J Lemke","year":"2014","unstructured":"Lemke J, Scheele J, Kapapa T, von Karstedt S, Wirtz CR, Henne-Bruns D, et al. Brain metastases in Gastrointestinal cancers: is there a role for surgery? Int J Mol Sci. 2014;15:16816\u201330.","journal-title":"Int J Mol Sci"},{"key":"3889_CR13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41575-018-0038-1","volume":"15","author":"N Murphy","year":"2018","unstructured":"Murphy N, Jenab M, Gunter MJ. Adiposity and Gastrointestinal cancers: epidemiology, mechanisms and future directions. Nat Rev Gastroenterol Hepatol. 2018;15:659\u201370.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3889_CR14","volume-title":"Current strategy to treat Immunogenic Gastrointestinal cancers","author":"K Shimozaki","year":"2023","unstructured":"Shimozaki K, Nakayama I, Hirota T, Yamaguchi K. Current strategy to treat Immunogenic Gastrointestinal cancers. Volume 12. Cells: Perspectives for a New Era; 2023."},{"key":"3889_CR15","doi-asserted-by":"publisher","first-page":"e2300824","DOI":"10.1002\/advs.202300824","volume":"10","author":"X Zhu","year":"2023","unstructured":"Zhu X, Li S. Ferroptosis, necroptosis, and pyroptosis in Gastrointestinal cancers: the chief culprits of tumor progression and drug resistance. Adv Sci (Weinh). 2023;10:e2300824.","journal-title":"Adv Sci (Weinh)"},{"key":"3889_CR16","doi-asserted-by":"crossref","unstructured":"Donlon NE, Power R, Hayes C, Davern M, Reynolds JV, Lysaght J. Radiation and immunotherapy in upper Gastrointestinal cancers: the current state of play. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22031071"},{"key":"3889_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcancer.2018.04.002","volume":"55","author":"CC Wong","year":"2019","unstructured":"Wong CC, Li W, Chan B, Yu J. Epigenomic biomarkers for prognostication and diagnosis of Gastrointestinal cancers. Semin Cancer Biol. 2019;55:90\u2013105.","journal-title":"Semin Cancer Biol"},{"key":"3889_CR18","doi-asserted-by":"publisher","first-page":"102854","DOI":"10.1016\/j.critrevonc.2019.102854","volume":"145","author":"P Naeli","year":"2020","unstructured":"Naeli P, Pourhanifeh MH, Karimzadeh MR, Shabaninejad Z, Movahedpour A, Tarrahimofrad H, et al. Circular RNAs and Gastrointestinal cancers: epigenetic regulators with a prognostic and therapeutic role. Crit Rev Oncol Hematol. 2020;145:102854.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3889_CR19","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1148\/rg.2018170159","volume":"38","author":"MG Lubner","year":"2018","unstructured":"Lubner MG, Menias CO, Johnson RJ, Gaballah AH, Shaaban A, Elsayes KM. Villous Gastrointestinal tumors: multimodality imaging with histopathologic correlation. Radiographics. 2018;38:1370\u201384.","journal-title":"Radiographics"},{"key":"3889_CR20","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s00262-022-03160-1","volume":"71","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Mislang ARA, Coward J, Cosman R, Cooper A, Underhill C, et al. Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper Gastrointestinal cancers. Cancer Immunol Immunother. 2022;71:2371\u20139.","journal-title":"Cancer Immunol Immunother"},{"key":"3889_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/14728222.2021.1937124","volume":"25","author":"AA Entezari","year":"2021","unstructured":"Entezari AA, Snook AE, Waldman SA. Guanylyl cyclase 2\u00a0C (GUCY2C) in Gastrointestinal cancers: recent innovations and therapeutic potential. Expert Opin Ther Targets. 2021;25:335\u201346.","journal-title":"Expert Opin Ther Targets"},{"key":"3889_CR22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.semcancer.2019.08.026","volume":"60","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Li J, Li D, Wang Z, Zhao J, Wu X, et al. Tumor biology and multidisciplinary strategies of oligometastasis in Gastrointestinal cancers. Semin Cancer Biol. 2020;60:334\u201343.","journal-title":"Semin Cancer Biol"},{"key":"3889_CR23","doi-asserted-by":"publisher","first-page":"987568","DOI":"10.3389\/fimmu.2022.987568","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zou J, Li Y, Jiao X, Wang Y, Zhuo N, et al. Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced Gastrointestinal cancers. Front Immunol. 2022;13:987568.","journal-title":"Front Immunol"},{"key":"3889_CR24","doi-asserted-by":"crossref","unstructured":"Fuc\u00e0 G, Cohen R, Lonardi S, Shitara K, Elez ME, Fakih M et al. Ascites and resistance to immune checkpoint Inhibition in dMMR\/MSI-H metastatic colorectal and gastric cancers. J Immunother Cancer. 2022;10.","DOI":"10.1136\/jitc-2021-004001"},{"key":"3889_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12943-016-0566-7","volume":"15","author":"T Huang","year":"2016","unstructured":"Huang T, Zhou Y, Cheng AS, Yu J, To KF, Kang W. NOTCH receptors in gastric and other Gastrointestinal cancers: oncogenes or tumor suppressors? Mol Cancer. 2016;15:80.","journal-title":"Mol Cancer"},{"key":"3889_CR26","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1038\/s41388-022-02479-4","volume":"41","author":"F Battaglin","year":"2022","unstructured":"Battaglin F, Jayachandran P, Strelez C, Lenz A, Algaze S, Soni S, et al. Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment. Oncogene. 2022;41:4769\u201378.","journal-title":"Oncogene"},{"key":"3889_CR27","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/ajg.2008.145","volume":"104","author":"FM Selaru","year":"2009","unstructured":"Selaru FM, David S, Meltzer SJ, Hamilton JP. Epigenetic events in Gastrointestinal cancer. Am J Gastroenterol. 2009;104:1910\u20132.","journal-title":"Am J Gastroenterol"},{"key":"3889_CR28","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1073\/pnas.93.19.10366","volume":"93","author":"PJ Lee","year":"1996","unstructured":"Lee PJ, Washer LL, Law DJ, Boland CR, Horon IL, Feinberg AP. Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. Proc Natl Acad Sci U S A. 1996;93:10366\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3889_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1479-5876-11-297","volume":"11","author":"M Pancione","year":"2013","unstructured":"Pancione M, Remo A, Zanella C, Sabatino L, Di Blasi A, Laudanna C, et al. The chromatin remodelling component SMARCB1\/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22. J Transl Med. 2013;11:297.","journal-title":"J Transl Med"},{"key":"3889_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ijc.1612","volume":"97","author":"T Kikuchi","year":"2002","unstructured":"Kikuchi T, Itoh F, Toyota M, Suzuki H, Yamamoto H, Fujita M, et al. Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer. Int J Cancer. 2002;97:272\u20137.","journal-title":"Int J Cancer"},{"key":"3889_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ceb.2013.01.007","volume":"25","author":"SS Hammoud","year":"2013","unstructured":"Hammoud SS, Cairns BR, Jones DA. Epigenetic regulation of colon cancer and intestinal stem cells. Curr Opin Cell Biol. 2013;25:177\u201383.","journal-title":"Curr Opin Cell Biol"},{"key":"3889_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41598-019-57214-z","volume":"10","author":"S Uribe-Lewis","year":"2020","unstructured":"Uribe-Lewis S, Carroll T, Menon S, Nicholson A, Manasterski PJ, Winton DJ, et al. 5-hydroxymethylcytosine and gene activity in mouse intestinal differentiation. Sci Rep. 2020;10:546.","journal-title":"Sci Rep"},{"key":"3889_CR33","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2407-11-450","volume":"11","author":"S Enroth","year":"2011","unstructured":"Enroth S, Rada-Iglesisas A, Andersson R, Wallerman O, Wanders A, P\u00e5hlman L, et al. Cancer associated epigenetic transitions identified by genome-wide histone methylation binding profiles in human colorectal cancer samples and paired normal mucosa. BMC Cancer. 2011;11:450.","journal-title":"BMC Cancer"},{"key":"3889_CR34","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1053\/j.gastro.2020.09.058","volume":"160","author":"WM Grady","year":"2021","unstructured":"Grady WM, Yu M, Markowitz SD. Epigenetic alterations in the Gastrointestinal tract: current and emerging use for biomarkers of Cancer. Gastroenterology. 2021;160:690\u2013709.","journal-title":"Gastroenterology"},{"key":"3889_CR35","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1038\/s41467-020-17227-z","volume":"11","author":"W Cao","year":"2020","unstructured":"Cao W, Lee H, Wu W, Zaman A, McCorkle S, Yan M, et al. Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma. Nat Commun. 2020;11:3675.","journal-title":"Nat Commun"},{"key":"3889_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12943-019-1099-7","volume":"18","author":"BB Hu","year":"2019","unstructured":"Hu BB, Wang XY, Gu XY, Zou C, Gao ZJ, Zhang H, et al. N(6)-methyladenosine (m(6)A) RNA modification in Gastrointestinal tract cancers: roles, mechanisms, and applications. Mol Cancer. 2019;18:178.","journal-title":"Mol Cancer"},{"key":"3889_CR37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/jmedgenet-2021-108327","volume":"59","author":"L Xiao","year":"2022","unstructured":"Xiao L, Wang J, Ju S, Cui M, Jing R. Disorders and roles of tsrna, snorna, SnRNA and PiRNA in cancer. J Med Genet. 2022;59:623\u201331.","journal-title":"J Med Genet"},{"key":"3889_CR38","doi-asserted-by":"publisher","first-page":"100974","DOI":"10.1016\/j.tranon.2020.100974","volume":"14","author":"L Ding","year":"2021","unstructured":"Ding L, Jiang M, Wang R, Shen D, Wang H, Lu Z, et al. The emerging role of small non-coding RNA in renal cell carcinoma. Transl Oncol. 2021;14:100974.","journal-title":"Transl Oncol"},{"key":"3889_CR39","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41392-021-00788-w","volume":"6","author":"C Xue","year":"2021","unstructured":"Xue C, Li G, Lu J, Li L. Crosstalk between circrnas and the PI3K\/AKT signaling pathway in cancer progression. Signal Transduct Target Ther. 2021;6:400.","journal-title":"Signal Transduct Target Ther"},{"key":"3889_CR40","doi-asserted-by":"crossref","unstructured":"Pardini B, Sabo AA, Birolo G, Calin GA. Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies, Cancers (Basel). 2019;11.","DOI":"10.3390\/cancers11081170"},{"key":"3889_CR41","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.tig.2017.09.002","volume":"33","author":"X Huang","year":"2017","unstructured":"Huang X, Fejes T\u00f3th K, Aravin AA. PiRNA biogenesis in Drosophila melanogaster. Trends Genet. 2017;33:882\u201394.","journal-title":"Trends Genet"},{"key":"3889_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-genet-120417-031441","volume":"52","author":"B Czech","year":"2018","unstructured":"Czech B, Munaf\u00f2 M, Ciabrelli F, Eastwood EL, Fabry MH, Kneuss E, et al. piRNA-Guided genome defense: from biogenesis to Silencing. Annu Rev Genet. 2018;52:131\u201357.","journal-title":"Annu Rev Genet"},{"key":"3889_CR43","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nature20162","volume":"539","author":"R Hayashi","year":"2016","unstructured":"Hayashi R, Schnabl J, Handler D, Mohn F, Ameres SL, Brennecke J. Genetic and mechanistic diversity of PiRNA 3\u2019-end formation. Nature. 2016;539:588\u201392.","journal-title":"Nature"},{"key":"3889_CR44","doi-asserted-by":"publisher","first-page":"1157818","DOI":"10.3389\/fnagi.2023.1157818","volume":"15","author":"K Sato","year":"2023","unstructured":"Sato K, Takayama KI, Inoue S. Role of PiRNA biogenesis and its neuronal function in the development of neurodegenerative diseases. Front Aging Neurosci. 2023;15:1157818.","journal-title":"Front Aging Neurosci"},{"key":"3889_CR45","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.cell.2007.01.043","volume":"128","author":"J Brennecke","year":"2007","unstructured":"Brennecke J, Aravin AA, Stark A, Dus M, Kellis M, Sachidanandam R, et al. Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila. Cell. 2007;128:1089\u2013103.","journal-title":"Cell"},{"key":"3889_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev-biochem-060614-034258","volume":"84","author":"YW Iwasaki","year":"2015","unstructured":"Iwasaki YW, Siomi MC, Siomi H. PIWI-Interacting RNA: its biogenesis and functions. Annu Rev Biochem. 2015;84:405\u201333.","journal-title":"Annu Rev Biochem"},{"key":"3889_CR47","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1093\/molbev\/mst081","volume":"30","author":"ES Kelleher","year":"2013","unstructured":"Kelleher ES, Barbash DA. Analysis of piRNA-mediated Silencing of active TEs in Drosophila melanogaster suggests limits on the evolution of host genome defense. Mol Biol Evol. 2013;30:1816\u201329.","journal-title":"Mol Biol Evol"},{"key":"3889_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40364-024-00563-3","volume":"12","author":"E Garcia-Borja","year":"2024","unstructured":"Garcia-Borja E, Siegl F, Mateu R, Slaby O, Sedo A, Busek P, et al. Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells. Biomark Res. 2024;12:15.","journal-title":"Biomark Res"},{"key":"3889_CR49","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12931-023-02367-9","volume":"24","author":"Y Yao","year":"2023","unstructured":"Yao Y, Li Y, Zhu X, Zhao C, Yang L, Huang X, et al. The emerging role of the pirna\/piwi complex in respiratory tract diseases. Respir Res. 2023;24:76.","journal-title":"Respir Res"},{"key":"3889_CR50","doi-asserted-by":"publisher","first-page":"903278","DOI":"10.3389\/fcell.2022.903278","volume":"10","author":"X Chen","year":"2022","unstructured":"Chen X, Xie W, Zhang M, Shi Y, Xu S, Cheng H, et al. The emerging role of Non-Coding RNAs in osteogenic differentiation of human bone marrow mesenchymal stem cells. Front Cell Dev Biol. 2022;10:903278.","journal-title":"Front Cell Dev Biol"},{"key":"3889_CR51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12943-019-1052-9","volume":"18","author":"Y Liu","year":"2019","unstructured":"Liu Y, Dou M, Song X, Dong Y, Liu S, Liu H, et al. The emerging role of the pirna\/piwi complex in cancer. Mol Cancer. 2019;18:123.","journal-title":"Mol Cancer"},{"key":"3889_CR52","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.2147\/CMAR.S209300","volume":"11","author":"Y Yu","year":"2019","unstructured":"Yu Y, Xiao J, Hann SS. The emerging roles of PIWI-interacting RNA in human cancers. Cancer Manag Res. 2019;11:5895\u2013909.","journal-title":"Cancer Manag Res"},{"key":"3889_CR53","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.omtn.2020.05.023","volume":"21","author":"X Wu","year":"2020","unstructured":"Wu X, Pan Y, Fang Y, Zhang J, Xie M, Yang F, et al. The biogenesis and functions of PiRNAs in human diseases. Mol Ther Nucleic Acids. 2020;21:108\u201320.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3889_CR54","doi-asserted-by":"publisher","first-page":"22390","DOI":"10.1073\/pnas.2008724117","volume":"117","author":"S Shi","year":"2020","unstructured":"Shi S, Yang ZZ, Liu S, Yang F, Lin H. PIWIL1 promotes gastric cancer via a piRNA-independent mechanism. Proc Natl Acad Sci U S A. 2020;117:22390\u2013401.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3889_CR55","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12964-023-01368-x","volume":"21","author":"Z Wu","year":"2023","unstructured":"Wu Z, Yu X, Zhang S, He Y, Guo W. Novel roles of PIWI proteins and PIWI-interacting RNAs in human health and diseases. Cell Commun Signal. 2023;21:343.","journal-title":"Cell Commun Signal"},{"key":"3889_CR56","doi-asserted-by":"publisher","first-page":"153757","DOI":"10.1016\/j.prp.2021.153757","volume":"230","author":"M Ameli Mojarad","year":"2022","unstructured":"Ameli Mojarad M, Ameli Mojarad M, Shojaee B, Nazemalhosseini-Mojarad E. PiRNA: A promising biomarker in early detection of Gastrointestinal cancer. Pathol Res Pract. 2022;230:153757.","journal-title":"Pathol Res Pract"},{"key":"3889_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1478-3231.2007.01624.x","volume":"28","author":"DS Sandhu","year":"2008","unstructured":"Sandhu DS, Shire AM, Roberts LR. Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets. Liver Int. 2008;28:12\u201327.","journal-title":"Liver Int"},{"key":"3889_CR58","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jhep.2013.01.032","volume":"58","author":"PT Law","year":"2013","unstructured":"Law PT, Qin H, Ching AK, Lai KP, Co NN, He M, et al. Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma. J Hepatol. 2013;58:1165\u201373.","journal-title":"J Hepatol"},{"key":"3889_CR59","doi-asserted-by":"publisher","first-page":"9151","DOI":"10.12659\/MSM.914222","volume":"24","author":"X Tang","year":"2018","unstructured":"Tang X, Xie X, Wang X, Wang Y, Jiang X, Jiang H. The combination of piR-823 and eukaryotic initiation factor 3 B (EIF3B) activates hepatic stellate cells via upregulating TGF-\u03b21 in liver fibrogenesis. Med Sci Monit. 2018;24:9151\u201365.","journal-title":"Med Sci Monit"},{"key":"3889_CR60","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.2147\/IJN.S398462","volume":"18","author":"T Rui","year":"2023","unstructured":"Rui T, Wang K, Xiang A, Guo J, Tang N, Jin X, et al. Serum Exosome-Derived PiRNAs could be promising biomarkers for HCC diagnosis. Int J Nanomed. 2023;18:1989\u20132001.","journal-title":"Int J Nanomed"},{"key":"3889_CR61","doi-asserted-by":"publisher","first-page":"1203821","DOI":"10.3389\/fonc.2023.1203821","volume":"13","author":"YJ Wu","year":"2023","unstructured":"Wu YJ, Wang J, Zhang P, Yuan LX, Ju LL, Wang HX, et al. PIWIL1 interacting RNA piR-017724 inhibits proliferation, invasion, and migration, and inhibits the development of HCC by Silencing PLIN3. Front Oncol. 2023;13:1203821.","journal-title":"Front Oncol"},{"key":"3889_CR62","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/CBM-230134","volume":"39","author":"G Hammad","year":"2024","unstructured":"Hammad G, Mamdouh S, Seoudi DM, Seleem MI, Safwat G, Mohamed RH. Elevated expression patterns of P-element induced wimpy testis (PIWI) transcripts are potential candidate markers for hepatocellular carcinoma. Cancer Biomark. 2024;39:95\u2013111.","journal-title":"Cancer Biomark"},{"key":"3889_CR63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2011.10.004","volume":"315","author":"J Cheng","year":"2012","unstructured":"Cheng J, Deng H, Xiao B, Zhou H, Zhou F, Shen Z, et al. piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. Cancer Lett. 2012;315:12\u20137.","journal-title":"Cancer Lett"},{"key":"3889_CR64","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.clinbiochem.2011.06.004","volume":"44","author":"L Cui","year":"2011","unstructured":"Cui L, Lou Y, Zhang X, Zhou H, Deng H, Song H, et al. Detection of Circulating tumor cells in peripheral blood from patients with gastric cancer using PiRNAs as markers. Clin Biochem. 2011;44:1050\u20137.","journal-title":"Clin Biochem"},{"key":"3889_CR65","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12943-018-0767-3","volume":"17","author":"W Weng","year":"2018","unstructured":"Weng W, Liu N, Toiyama Y, Kusunoki M, Nagasaka T, Fujiwara T, et al. Novel evidence for a PIWI-interacting RNA (piRNA) as an oncogenic mediator of disease progression, and a potential prognostic biomarker in colorectal cancer. Mol Cancer. 2018;17:16.","journal-title":"Mol Cancer"},{"key":"3889_CR66","doi-asserted-by":"crossref","unstructured":"Vinasco-Sandoval T, Moreira FC, Pinto AFV, Ribeiro-Dos-Santos P, Cruz AM. R. L. S., Global analyses of expressed Piwi-Interacting RNAs in gastric Cancer. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21207656"},{"key":"3889_CR67","doi-asserted-by":"publisher","first-page":"14502","DOI":"10.1111\/jcmm.16077","volume":"24","author":"L Ge","year":"2020","unstructured":"Ge L, Zhang N, Li D, Wu Y, Wang H, Wang J. Circulating Exosomal small RNAs are promising non-invasive diagnostic biomarkers for gastric cancer. J Cell Mol Med. 2020;24:14502\u201313.","journal-title":"J Cell Mol Med"},{"key":"3889_CR68","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.7150\/thno.28001","volume":"8","author":"D Mai","year":"2018","unstructured":"Mai D, Ding P, Tan L, Zhang J, Pan Z, Bai R, et al. PIWI-interacting RNA-54265 is oncogenic and a potential therapeutic target in colorectal adenocarcinoma. Theranostics. 2018;8:5213\u201330.","journal-title":"Theranostics"},{"key":"3889_CR69","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/1055-9965.EPI-18-0318","volume":"27","author":"P Vychytilova-Faltejskova","year":"2018","unstructured":"Vychytilova-Faltejskova P, Stitkovcova K, Radova L, Sachlova M, Kosarova Z, Slaba K, et al. Circulating PIWI-Interacting RNAs piR-5937 and piR-28876 are promising diagnostic biomarkers of Colon cancer. Cancer Epidemiol Biomarkers Prev. 2018;27:1019\u201328.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3889_CR70","doi-asserted-by":"crossref","unstructured":"Iyer DN, Wan TM, Man JH, Sin RW, Li X, Lo OS et al. Small RNA profiling of PiRNAs in colorectal Cancer identifies consistent overexpression of piR-24000 that correlates clinically with an aggressive disease phenotype. Cancers (Basel). 2020;12.","DOI":"10.3390\/cancers12010188"},{"key":"3889_CR71","doi-asserted-by":"publisher","first-page":"8468","DOI":"10.7150\/thno.46241","volume":"10","author":"D Mai","year":"2020","unstructured":"Mai D, Zheng Y, Guo H, Ding P, Bai R, Li M, et al. Serum piRNA-54265 is a new biomarker for early detection and clinical surveillance of human colorectal Cancer. Theranostics. 2020;10:8468\u201378.","journal-title":"Theranostics"},{"key":"3889_CR72","doi-asserted-by":"crossref","unstructured":"Sabbah NA, Abdalla WM, Mawla WA, AbdAlMonem N, Gharib AF, Abdul-Saboor A et al. piRNA-823 is a unique potential diagnostic Non-Invasive biomarker in colorectal Cancer patients. Genes (Basel). 2021;12.","DOI":"10.3390\/genes12040598"},{"key":"3889_CR73","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-015-0358-5","volume":"14","author":"S M\u00fcller","year":"2015","unstructured":"M\u00fcller S, Raulefs S, Bruns P, Afonso-Grunz F, Pl\u00f6tner A, Thermann R, et al. Next-generation sequencing reveals novel differentially regulated mRNAs, lncrnas, mirnas, SdRNAs and a PiRNA in pancreatic cancer. Mol Cancer. 2015;14:94.","journal-title":"Mol Cancer"},{"key":"3889_CR74","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1038\/s41598-020-59523-0","volume":"10","author":"SR Kumar","year":"2020","unstructured":"Kumar SR, Kimchi ET, Manjunath Y, Gajagowni S, Stuckel AJ, Kaifi J. T., RNA cargos in extracellular vesicles derived from blood serum in pancreas associated conditions. Sci Rep. 2020;10:2800.","journal-title":"Sci Rep"},{"key":"3889_CR75","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s13577-020-00463-2","volume":"34","author":"J Xie","year":"2021","unstructured":"Xie J, Xing S, Shen BY, Chen HT, Sun B, Wang ZT, et al. PIWIL1 interacting RNA piR-017061 inhibits pancreatic cancer growth via regulating EFNA5. Hum Cell. 2021;34:550\u201363.","journal-title":"Hum Cell"},{"key":"3889_CR76","doi-asserted-by":"publisher","first-page":"152848","DOI":"10.1016\/j.prp.2020.152848","volume":"216","author":"JF Su","year":"2020","unstructured":"Su JF, Zhao F, Gao ZW, Hou YJ, Li YY, Duan LJ, et al. piR-823 demonstrates tumor oncogenic activity in esophageal squamous cell carcinoma through DNA methylation induction via DNA methyltransferase 3B. Pathol Res Pract. 2020;216:152848.","journal-title":"Pathol Res Pract"},{"key":"3889_CR77","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-021-01104-3","volume":"14","author":"S Chen","year":"2021","unstructured":"Chen S, Ben S, Xin J, Li S, Zheng R, Wang H, et al. The biogenesis and biological function of PIWI-interacting RNA in cancer. J Hematol Oncol. 2021;14:93.","journal-title":"J Hematol Oncol"},{"key":"3889_CR78","doi-asserted-by":"crossref","unstructured":"Fonseca Cabral G, Azevedo Dos Santos Pinheiro J, Vidal AF, Santos S. Ribeiro-Dos-Santos \u00c2., PiRNAs in gastric cancer: A new approach towards translational research. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21062126"},{"key":"3889_CR79","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12935-021-02034-3","volume":"21","author":"F Sadoughi","year":"2021","unstructured":"Sadoughi F, Mirhashemi SM, Asemi Z. Epigenetic roles of PIWI proteins and PiRNAs in colorectal cancer. Cancer Cell Int. 2021;21:328.","journal-title":"Cancer Cell Int"},{"key":"3889_CR80","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.canlet.2020.06.022","volume":"493","author":"S Xie","year":"2020","unstructured":"Xie S, Chang Y, Jin H, Yang F, Xu Y, Yan X, et al. Non-coding RNAs in gastric cancer. Cancer Lett. 2020;493:55\u201370.","journal-title":"Cancer Lett"},{"key":"3889_CR81","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41580-022-00528-0","volume":"24","author":"X Wang","year":"2023","unstructured":"Wang X, Ramat A, Simonelig M, Liu MF. Emerging roles and functional mechanisms of PIWI-interacting RNAs. Nat Rev Mol Cell Biol. 2023;24:123\u201341.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3889_CR82","doi-asserted-by":"crossref","unstructured":"Li Y, Al Hallak MN, Azmi PPA, Mohammad AS. R. M., Non-Coding RNAs in pancreatic Cancer diagnostics and therapy: focus on lncrnas, circrnas, and PiRNAs. Cancers (Basel). 2021;13.","DOI":"10.3390\/cancers13164161"},{"key":"3889_CR83","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-023-01749-3","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zhu Y, Cao X, Tan W, Yu J, Lu Y, et al. The epigenetic regulatory mechanism of piwi\/pirnas in human cancers. Mol Cancer. 2023;22:45.","journal-title":"Mol Cancer"},{"key":"3889_CR84","doi-asserted-by":"publisher","first-page":"115527","DOI":"10.1016\/j.biopha.2023.115527","volume":"167","author":"X Zhang","year":"2023","unstructured":"Zhang X, Xu X, Song J, Xu Y, Qian H, Jin J, et al. Non-coding rnas\u2019 function in cancer development, diagnosis and therapy. Biomed Pharmacother. 2023;167:115527.","journal-title":"Biomed Pharmacother"},{"key":"3889_CR85","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13045-022-01230-6","volume":"15","author":"R Zhao","year":"2022","unstructured":"Zhao R, Fu J, Zhu L, Chen Y, Liu B. Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy. J Hematol Oncol. 2022;15:14.","journal-title":"J Hematol Oncol"},{"key":"3889_CR86","doi-asserted-by":"publisher","first-page":"188491","DOI":"10.1016\/j.bbcan.2020.188491","volume":"1875","author":"S Toden","year":"2021","unstructured":"Toden S, Zumwalt TJ, Goel A. Non-coding RNAs and potential therapeutic targeting in cancer. Biochim Biophys Acta Rev Cancer. 2021;1875:188491.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3889_CR87","doi-asserted-by":"crossref","unstructured":"Be\u0148a\u010dka R, Szab\u00f3ov\u00e1 D, Gu\u013ea\u0161ov\u00e1 Z, Hertelyov\u00e1 Z, Rado\u0148ak J. Non-Coding RNAs in human Cancer and other diseases: overview of the diagnostic potential. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms242216213"},{"key":"3889_CR88","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1111\/cas.13300","volume":"108","author":"J Yin","year":"2017","unstructured":"Yin J, Jiang XY, Qi W, Ji CG, Xie XL, Zhang DX, et al. piR-823 contributes to colorectal tumorigenesis by enhancing the transcriptional activity of HSF1. Cancer Sci. 2017;108:1746\u201356.","journal-title":"Cancer Sci"},{"key":"3889_CR89","doi-asserted-by":"publisher","first-page":"19886","DOI":"10.3390\/ijms160819886","volume":"16","author":"J Wang","year":"2015","unstructured":"Wang J, Song YX, Ma B, Wang JJ, Sun JX, Chen XW, et al. Regulatory roles of Non-Coding RNAs in colorectal Cancer. Int J Mol Sci. 2015;16:19886\u2013919.","journal-title":"Int J Mol Sci"},{"key":"3889_CR90","doi-asserted-by":"crossref","unstructured":"Lampropoulou DI, Pliakou E, Aravantinos G, Filippou D, Gazouli M. The role of Exosomal Non-Coding RNAs in colorectal Cancer drug resistance. Int J Mol Sci. 2022;23.","DOI":"10.3390\/ijms23031473"},{"key":"3889_CR91","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/abbs\/gmv018","volume":"47","author":"Y Tan","year":"2015","unstructured":"Tan Y, Liu L, Liao M, Zhang C, Hu S, Zou M, et al. Emerging roles for PIWI proteins in cancer. Acta Biochim Biophys Sin (Shanghai). 2015;47:315\u201324.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"3889_CR92","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1111\/jcmm.16466","volume":"25","author":"K Wang","year":"2021","unstructured":"Wang K, Wang T, Gao XQ, Chen XZ, Wang F, Zhou LY. Emerging functions of piwi-interacting RNAs in diseases. J Cell Mol Med. 2021;25:4893\u2013901.","journal-title":"J Cell Mol Med"},{"key":"3889_CR93","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41388-020-01630-3","volume":"40","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zhang J, Diao L, Han L. Small non-coding RNAs in human cancer: function, clinical utility, and characterization. Oncogene. 2021;40:1570\u20137.","journal-title":"Oncogene"},{"key":"3889_CR94","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s10120-015-0487-y","volume":"19","author":"VD Martinez","year":"2016","unstructured":"Martinez VD, Enfield KSS, Rowbotham DA, Lam WL. An atlas of gastric PIWI-interacting RNA transcriptomes and their utility for identifying signatures of gastric cancer recurrence. Gastric Cancer. 2016;19:660\u20135.","journal-title":"Gastric Cancer"},{"key":"3889_CR95","doi-asserted-by":"publisher","first-page":"1069637","DOI":"10.3389\/fgene.2022.1069637","volume":"13","author":"AN Akimniyazova","year":"2022","unstructured":"Akimniyazova AN, Niyazova TK, Yurikova OY, Pyrkova AY, Zhanuzakov MA, Ivashchenko AT. PiRNAs May regulate expression of candidate genes of esophageal adenocarcinoma. Front Genet. 2022;13:1069637.","journal-title":"Front Genet"},{"key":"3889_CR96","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.3390\/cimb45070387","volume":"45","author":"A Rakhmetullina","year":"2023","unstructured":"Rakhmetullina A, Akimniyazova A, Niyazova T, Pyrkova A, Tauassarova M, Ivashchenko A, et al. Interactions of PiRNAs with the mRNA of candidate genes in esophageal squamous cell carcinoma. Curr Issues Mol Biol. 2023;45:6140\u201353.","journal-title":"Curr Issues Mol Biol"},{"key":"3889_CR97","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/516S1a","volume":"516","author":"L Gravitz","year":"2014","unstructured":"Gravitz L. Liver cancer. Nature. 2014;516:S1.","journal-title":"Nature"},{"key":"3889_CR98","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, et al. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther. 2023;8:204.","journal-title":"Signal Transduct Target Ther"},{"key":"3889_CR99","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.semcancer.2010.11.002","volume":"21","author":"JG Chen","year":"2011","unstructured":"Chen JG, Zhang SW. Liver cancer epidemic in china: past, present and future. Semin Cancer Biol. 2011;21:59\u201369.","journal-title":"Semin Cancer Biol"},{"key":"3889_CR100","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1016\/j.jhep.2015.02.007","volume":"62","author":"J Bruix","year":"2015","unstructured":"Bruix J, Han KH, Gores G, Llovet JM, Mazzaferro V. Liver cancer: approaching a personalized care. J Hepatol. 2015;62:S144\u201356.","journal-title":"J Hepatol"},{"key":"3889_CR101","doi-asserted-by":"publisher","first-page":"7967","DOI":"10.1038\/s41598-018-26360-1","volume":"8","author":"SV Koduru","year":"2018","unstructured":"Koduru SV, Leberfinger AN, Kawasawa YI, Mahajan M, Gusani NJ, Sanyal AJ, et al. Non-coding RNAs in various stages of liver disease leading to hepatocellular carcinoma: differential expression of mirnas, pirnas, lncrnas, circrnas, and sno\/mt-RNAs. Sci Rep. 2018;8:7967.","journal-title":"Sci Rep"},{"key":"3889_CR102","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2013.10.021","volume":"344","author":"Y He","year":"2014","unstructured":"He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW, et al. Long noncoding rnas: novel insights into hepatocelluar carcinoma. Cancer Lett. 2014;344:20\u20137.","journal-title":"Cancer Lett"},{"key":"3889_CR103","first-page":"3829","volume":"19","author":"X Ma","year":"2020","unstructured":"Ma X, Huang Y, Ding Y, Shi L, Zhong X, Kang M, et al. Analysis of PiRNA expression spectra in a non-alcoholic fatty liver disease mouse model induced by a methionine- and choline-deficient diet. Exp Ther Med. 2020;19:3829\u201339.","journal-title":"Exp Ther Med"},{"key":"3889_CR104","first-page":"3395","volume":"15","author":"Z Xiao","year":"2018","unstructured":"Xiao Z, Shen J, Zhang L, Li M, Hu W, Cho C. Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: recent progress and future prospects. Oncol Lett. 2018;15:3395\u2013402.","journal-title":"Oncol Lett"},{"key":"3889_CR105","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1373\/clinchem.2018.301150","volume":"65","author":"C Tan","year":"2019","unstructured":"Tan C, Cao J, Chen L, Xi X, Wang S, Zhu Y, et al. Noncoding RNAs serve as diagnosis and prognosis biomarkers for hepatocellular carcinoma. Clin Chem. 2019;65:905\u201315.","journal-title":"Clin Chem"},{"key":"3889_CR106","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1080\/1354750X.2020.1794041","volume":"25","author":"J Xu","year":"2020","unstructured":"Xu J, Yang X, Zhou Q, Zhuang J, Han S. Biological significance of PiRNA in liver cancer: a review. Biomarkers. 2020;25:436\u201340.","journal-title":"Biomarkers"},{"key":"3889_CR107","doi-asserted-by":"publisher","first-page":"110400","DOI":"10.1016\/j.mehy.2020.110400","volume":"146","author":"J Zhou","year":"2021","unstructured":"Zhou J, Zhou W, Zhang R. The potential mechanisms of PiRNA to induce hepatocellular carcinoma in human. Med Hypotheses. 2021;146:110400.","journal-title":"Med Hypotheses"},{"key":"3889_CR108","doi-asserted-by":"publisher","first-page":"54650","DOI":"10.18632\/oncotarget.10567","volume":"7","author":"F Rizzo","year":"2016","unstructured":"Rizzo F, Rinaldi A, Marchese G, Coviello E, Sellitto A, Cordella A, et al. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma. Oncotarget. 2016;7:54650\u201361.","journal-title":"Oncotarget"},{"key":"3889_CR109","doi-asserted-by":"crossref","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367.","DOI":"10.1126\/science.aau6977"},{"key":"3889_CR110","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","volume":"11","author":"Y Liang","year":"2021","unstructured":"Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11:3183\u201395.","journal-title":"Theranostics"},{"key":"3889_CR111","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel DM, Gould SJ, Exosomes. Annu Rev Biochem. 2019;88:487\u2013514.","journal-title":"Annu Rev Biochem"},{"key":"3889_CR112","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbcan.2019.04.004","volume":"1871","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta Rev Cancer. 2019;1871:455\u201368.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3889_CR113","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.3748\/wjg.v20.i18.5411","volume":"20","author":"PF Li","year":"2014","unstructured":"Li PF, Chen SC, Xia T, Jiang XM, Shao YF, Xiao BX, et al. Non-coding RNAs and gastric cancer. World J Gastroenterol. 2014;20:5411\u20139.","journal-title":"World J Gastroenterol"},{"key":"3889_CR114","doi-asserted-by":"publisher","first-page":"6610","DOI":"10.3748\/wjg.v22.i29.6610","volume":"22","author":"M Zhang","year":"2016","unstructured":"Zhang M, Du X. Noncoding RNAs in gastric cancer: research progress and prospects. World J Gastroenterol. 2016;22:6610\u20138.","journal-title":"World J Gastroenterol"},{"key":"3889_CR115","first-page":"3089","volume":"41","author":"X Lin","year":"2019","unstructured":"Lin X, Xia Y, Hu D, Mao Q, Yu Z, Zhang H, et al. Transcriptome\u2013wide PiRNA profiling in human gastric cancer. Oncol Rep. 2019;41:3089\u201399.","journal-title":"Oncol Rep"},{"key":"3889_CR116","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13046-022-02318-0","volume":"41","author":"A Raza","year":"2022","unstructured":"Raza A, Khan AQ, Inchakalody VP, Mestiri S, Yoosuf Z, Bedhiafi T, et al. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer. J Exp Clin Cancer Res. 2022;41:99.","journal-title":"J Exp Clin Cancer Res"},{"key":"3889_CR117","doi-asserted-by":"publisher","first-page":"145063","DOI":"10.1016\/j.gene.2020.145063","volume":"769","author":"Z Jing","year":"2021","unstructured":"Jing Z, Xi Y, Yin J, Shuwen H. Biological roles of PiRNAs in colorectal cancer. Gene. 2021;769:145063.","journal-title":"Gene"},{"key":"3889_CR118","doi-asserted-by":"crossref","unstructured":"Yuan C, Qin H, Ponnusamy M, Chen Y, Lin Z. PIWI\u2013interacting RNA in cancer: molecular mechanisms and possible clinical implications (Review). Oncol Rep. 2021;46.","DOI":"10.3892\/or.2021.8160"},{"key":"3889_CR119","doi-asserted-by":"publisher","first-page":"e00113","DOI":"10.1016\/j.plabm.2018.e00113","volume":"13","author":"GM Chalbatani","year":"2019","unstructured":"Chalbatani GM, Dana H, Memari F, Gharagozlou E, Ashjaei S, Kheirandish P, et al. Biological function and molecular mechanism of PiRNA in cancer. Pract Lab Med. 2019;13:e00113.","journal-title":"Pract Lab Med"},{"key":"3889_CR120","first-page":"263","volume":"42","author":"J Yin","year":"2019","unstructured":"Yin J, Qi W, Ji CG, Zhang DX, Xie XL, Ding Q, et al. Small RNA sequencing revealed aberrant PiRNA expression profiles in colorectal cancer. Oncol Rep. 2019;42:263\u201372.","journal-title":"Oncol Rep"},{"key":"3889_CR121","doi-asserted-by":"publisher","first-page":"340896","DOI":"10.1016\/j.aca.2023.340896","volume":"1246","author":"H Chen","year":"2023","unstructured":"Chen H, Zhuang Z, Chen Y, Qiu C, Qin Y, Tan C, et al. A universal platform for one-pot detection of Circulating non-coding RNA combining CRISPR-Cas12a and branched rolling circle amplification. Anal Chim Acta. 2023;1246:340896.","journal-title":"Anal Chim Acta"},{"key":"3889_CR122","doi-asserted-by":"publisher","first-page":"e0294685","DOI":"10.1371\/journal.pone.0294685","volume":"18","author":"EJ Sohn","year":"2023","unstructured":"Sohn EJ, Han ME, Park YM, Kim YH, Oh SO. The potential of piR-823 as a diagnostic biomarker in oncology: A systematic review. PLoS ONE. 2023;18:e0294685.","journal-title":"PLoS ONE"},{"key":"3889_CR123","doi-asserted-by":"publisher","first-page":"124307","DOI":"10.1016\/j.talanta.2023.124307","volume":"257","author":"Y Tong","year":"2023","unstructured":"Tong Y, Guan B, Sun Z, Dong X, Chen Y, Li Y, et al. Ratiometric fluorescent detection of Exosomal piRNA-823 based on Au NCs\/UiO-66-NH(2) and target-triggered rolling circle amplification. Talanta. 2023;257:124307.","journal-title":"Talanta"},{"key":"3889_CR124","doi-asserted-by":"publisher","first-page":"9028","DOI":"10.1111\/jcmm.15537","volume":"24","author":"J Feng","year":"2020","unstructured":"Feng J, Yang M, Wei Q, Song F, Zhang Y, Wang X, et al. Novel evidence for oncogenic piRNA-823 as a promising prognostic biomarker and a potential therapeutic target in colorectal cancer. J Cell Mol Med. 2020;24:9028\u201340.","journal-title":"J Cell Mol Med"},{"key":"3889_CR125","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s10528-023-10348-2","volume":"61","author":"Q Liu","year":"2023","unstructured":"Liu Q, Chen Q, Zhou Z, Tian Z, Zheng X, Wang K. piRNA-18 Inhibition cell proliferation, migration and invasion in colorectal Cancer. Biochem Genet. 2023;61:1881\u201397.","journal-title":"Biochem Genet"},{"key":"3889_CR126","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein AP. Pancreatic cancer epidemiology: Understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021;18:493\u2013502.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3889_CR127","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","volume":"378","author":"A Vincent","year":"2011","unstructured":"Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607\u201320.","journal-title":"Lancet"},{"key":"3889_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","volume":"520","author":"J Cai","year":"2021","unstructured":"Cai J, Chen H, Lu M, Zhang Y, Lu B, You L, et al. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis. Cancer Lett. 2021;520:1\u201311.","journal-title":"Cancer Lett"},{"key":"3889_CR129","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","volume":"164","author":"EM Stoffel","year":"2023","unstructured":"Stoffel EM, Brand RE, Goggins M. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology. 2023;164:752\u201365.","journal-title":"Gastroenterology"},{"key":"3889_CR130","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12943-020-01169-7","volume":"19","author":"C Qin","year":"2020","unstructured":"Qin C, Yang G, Yang J, Ren B, Wang H, Chen G, et al. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Mol Cancer. 2020;19:50.","journal-title":"Mol Cancer"},{"key":"3889_CR131","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3748\/wjg.v22.i2.801","volume":"22","author":"JF Peng","year":"2016","unstructured":"Peng JF, Zhuang YY, Huang FT, Zhang SN. Noncoding RNAs and pancreatic cancer. World J Gastroenterol. 2016;22:801\u201314.","journal-title":"World J Gastroenterol"},{"key":"3889_CR132","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-015-0401-6","volume":"14","author":"S M\u00fcller","year":"2015","unstructured":"M\u00fcller S, Raulefs S, Bruns P, Afonso-Grunz F, Pl\u00f6tner A, Thermann R, et al. Erratum to: Next-generation sequencing reveals novel differentially regulated mRNAs, lncrnas, mirnas, SdRNAs and a PiRNA in pancreatic cancer. Mol Cancer. 2015;14:144.","journal-title":"Mol Cancer"},{"key":"3889_CR133","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41556-020-0486-z","volume":"22","author":"F Li","year":"2020","unstructured":"Li F, Yuan P, Rao M, Jin CH, Tang W, Rong YF, et al. piRNA-independent function of PIWIL1 as a co-activator for anaphase promoting complex\/cyclosome to drive pancreatic cancer metastasis. Nat Cell Biol. 2020;22:425\u201338.","journal-title":"Nat Cell Biol"},{"key":"3889_CR134","doi-asserted-by":"publisher","first-page":"C1624","DOI":"10.1152\/ajpcell.00424.2022","volume":"323","author":"MH Uddin","year":"2022","unstructured":"Uddin MH, Mohammad RM, Azmi PPA, Muqbil AS. Role of noncoding RNAs in pancreatic ductal adenocarcinoma associated cachexia. Am J Physiol Cell Physiol. 2022;323:C1624\u201332.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3889_CR135","doi-asserted-by":"publisher","first-page":"8527","DOI":"10.3748\/wjg.v21.i28.8527","volume":"21","author":"T Kishikawa","year":"2015","unstructured":"Kishikawa T, Otsuka M, Ohno M, Yoshikawa T, Takata A, Koike K. Circulating RNAs as new biomarkers for detecting pancreatic cancer. World J Gastroenterol. 2015;21:8527\u201340.","journal-title":"World J Gastroenterol"},{"key":"3889_CR136","doi-asserted-by":"crossref","unstructured":"Li W, Gonzalez-Gonzalez M, Sanz-Criado L, Garcia-Carbonero N, Celdran A, Villarejo-Campos P et al. A novel PiRNA enhances CA19-9 sensitivity for pancreatic Cancer identification by liquid biopsy. J Clin Med. 2022;11.","DOI":"10.3390\/jcm11247310"},{"key":"3889_CR137","doi-asserted-by":"crossref","unstructured":"Belkozhayev A, Niyazova R, Wilson C, Jainakbayev N, Pyrkova A, Ashirbekov Y et al. Bioinformatics analysis of the interaction of MiRNAs and PiRNAs with human mRNA genes having di- and trinucleotide repeats. Genes (Basel). 2022;13.","DOI":"10.3390\/genes13050800"},{"key":"3889_CR138","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/1874467212666190215112915","volume":"12","author":"J Kaur","year":"2019","unstructured":"Kaur J, Daoud A, Eblen ST. Targeting chromatin remodeling for Cancer therapy. Curr Mol Pharmacol. 2019;12:215\u201329.","journal-title":"Curr Mol Pharmacol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03889-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03889-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03889-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:04:20Z","timestamp":1751447060000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03889-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":138,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3889"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03889-6","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}